Brief: Spectral Enters Into Technology Transfer Transaction And Provides Update On US FDA Process
01/10/2018 13:40
Oct 1 (Reuters) - Spectral Medical Inc EDT.TO :
* SPECTRAL ENTERS INTO TECHNOLOGY TRANSFER TRANSACTION AND
PROVIDES UPDATE ON US FDA PROCESS
* SPECTRAL MEDICAL INC - HAS TRANSFERRED CERTAIN TECHNOLOGY
AND
RELATED MATERIALS TO AN UNDISCLOSED THIRD PARTY.
* SPECTRAL MEDICAL INC - UNDER TERMS OF AGREEMENT, THERE ARE
4
MILESTONES WHICH ARE TARGETED TO BE MET IN 2018 & 2019
Source text for Eikon: ID:nGNX9jfXW3
Further company coverage: EDT.TO
(Reuters.Briefs@thomsonreuters.com)
Recent news on Spectral Medical
See all newsBrief: Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting For PMX PMA
Canada's Spectral Medical Q2 revenue falls on lower reagent sales
Brief: Spectral Medical And Vantive Announce Topline 12 Month Follow-Up Results From Spectral’S Tigris Trial
Canada's Spectral Medical Q1 revenue rises 56%, net loss narrows
Spectral Medical Q3 revenue up 34%